Cuu Long Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DCL1
VND
57,600.00
100 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DHG Pharmaceutical JSC
Mediplantex National Pharmaceutical JSC
OPC Pharmaceutical JSC
Domesco Medical Import-Export JSC
Binh Dinh Pharmaceutical & Medical Equipment JSC
F.I.T. Investment JSC
Ben Tre Pharmaceutical JSC
Imexpharm Corp.
Ha Tay Pharmaceutical JSC
Cuu Long Pharmaceutical JSC
Mekophar Chemical Pharmaceutical JSC

Why is Cuu Long Pharmaceutical JSC ?

1
  • INTEREST(HY) At VND 26,426.22 MM has Grown at 111.64%
  • ROCE(HY) Lowest at 2.35%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.05 times
2
With ROE of 2.84%, it has a expensive valuation with a 1.43 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 140.50%, its profits have fallen by -32.4%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cuu Long Pharmaceutical JSC for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Cuu Long Pharmaceutical JSC
140.5%
2.14
44.53%
Vietnam VN Ho Chi Minh Index
43.59%
1.93
22.62%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.25%
EBIT Growth (5y)
10.79%
EBIT to Interest (avg)
2.58
Debt to EBITDA (avg)
0.80
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.60
Tax Ratio
23.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.46%
ROE (avg)
6.63%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
1.43
EV to EBIT
39.07
EV to EBITDA
23.58
EV to Capital Employed
1.32
EV to Sales
1.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.38%
ROE (Latest)
2.84%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
OPERATING CASH FLOW(Y)

Highest at VND 23,154.54 MM

-33What is not working for the Company
INTEREST(HY)

At VND 26,426.22 MM has Grown at 111.64%

ROCE(HY)

Lowest at 2.35%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.05 times

INTEREST COVERAGE RATIO(Q)

Lowest at 101.42

RAW MATERIAL COST(Y)

Grown by 21.23% (YoY

CASH AND EQV(HY)

Lowest at VND 505,034.34 MM

DEBT-EQUITY RATIO (HY)

Highest at 38.5 %

PRE-TAX PROFIT(Q)

Lowest at VND -5,368.84 MM

NET PROFIT(Q)

Lowest at VND -5,936.97 MM

EPS(Q)

Lowest at VND -81.28

Here's what is working for Cuu Long Pharmaceutical JSC

Operating Cash Flow
Highest at VND 23,154.54 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Depreciation
Highest at VND 13,732.82 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (VND MM)

Here's what is not working for Cuu Long Pharmaceutical JSC

Interest
At VND 26,426.22 MM has Grown at 111.64%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Pre-Tax Profit
At VND -5,368.84 MM has Fallen at -331.55%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (VND MM)

Net Profit
At VND -5,936.97 MM has Fallen at -519.76%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (VND MM)

Interest Coverage Ratio
Lowest at 101.42
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debtors Turnover Ratio
Lowest at 2.05 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Pre-Tax Profit
Lowest at VND -5,368.84 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (VND MM)

Net Profit
Lowest at VND -5,936.97 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (VND MM)

EPS
Lowest at VND -81.28
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Cash and Eqv
Lowest at VND 505,034.34 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 38.5 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 21.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales